Live from the NIH registry
Studies recruiting near Jackson right now
Top 25 of 223 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Children's Oncology Group
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Flowood, Mississippi (4.3 mi)
· Sponsor: Akero Therapeutics, Inc
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Jackson, Mississippi (2.0 mi)
· Sponsor: Sameek Roychowdhury
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Heart Failure, Cardiorenal Syndrome
N/A
Interventional 320 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Procyrion
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Healthy Volunteers, Pulmonary Arterial Hypertension
Phase 1, Phase 2
Interventional 232 participants sought
Sky Integrative Medical Center SKYCRNG PPDS — Ridgeland, Mississippi (9.1 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Major Depressive Disorder (MDD)
Phase 2
Interventional 300 participants sought
Draig Clinical Site — Flowood, Mississippi (4.3 mi)
· Sponsor: Draig Therapeutics Ltd
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Intervention to Enhance PrEP Persistence
HIV Prevention, HIV Infection Primary
N/A
Interventional 300 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Brown University
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Phase 4
Interventional 100 participants sought
St. Dominic - Jackson Memorial Hospital — Jackson, Mississippi (2.0 mi)
· Sponsor: Pfizer
Zimmer Biomet Shoulder Arthroplasty PMCF
Shoulder Fractures, Shoulder Arthritis
N/A
Interventional 584 participants sought
Mississippi Sports Medicine and Orthopaedic Center, PLLC — Jackson, Mississippi (2.0 mi)
· Sponsor: Zimmer Biomet
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
Acute Respiratory Distress Syndrome, ARDS
Phase 3
Interventional 970 participants sought
Direct Biologics Investigational Site — Jackson, Mississippi (2.0 mi)
· Sponsor: Direct Biologics, LLC
The PERSEVERE Study
Pulmonary Embolism, Pulmonary Thromboembolism
N/A
Interventional 200 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Inari Medical
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Phase 3
Interventional 274 participants sought
Precise Research Centers — Flowood, Mississippi (4.3 mi)
· Sponsor: Bristol-Myers Squibb
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
GI Associates - GIA and Endoscopy Center - Flowood — Flowood, Mississippi (4.3 mi)
· Sponsor: Eli Lilly and Company
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors
Solid Tumor
Phase 1
Interventional 200 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Oxford BioTherapeutics Ltd
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
Pancreatic Cancer
N/A
Observational 125 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
Hemorrhagic Shock, Trauma Injury
Phase 3
Interventional 1,000 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Philip Spinella
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Flowood, Mississippi (4.3 mi)
· Sponsor: 89bio, Inc.
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
Hypertension
N/A
Interventional 261 participants sought
Jackson Heart Clinic — Jackson, Mississippi (2.0 mi)
· Sponsor: SoniVie Inc.
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss
Obesity & Overweight, Mobility Disability
Phase 2
Interventional 200 participants sought
SKY Integrative Medical Center — Ridgeland, Mississippi (9.1 mi)
· Sponsor: Veru Inc.
Follow-up Visit of High Risk Infants
Infant, Newborn, Infant, Low Birth Weight
N/A
Observational 68,000 participants sought
University of Mississippi Medical Center - Children's of Mississippi — Jackson, Mississippi (2.0 mi)
· Sponsor: NICHD Neonatal Research Network
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Children's Oncology Group
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Sickle Cell Disease
Phase 2, Phase 3
Interventional 389 participants sought
Southern Specialty Research — Flowood, Mississippi (4.3 mi)
· Sponsor: Pfizer
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Jackson Heart Clinic — Jackson, Mississippi (2.0 mi)
· Sponsor: Amgen